Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Seibert

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|March 1, 1995
Regulation of prostaglandin production by nitric oxide; an in vivo analysisD Salvemini, S L Settle, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Nitric oxide activates cyclooxygenase enzymesD Salvemini, T P Misko, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and painK Seibert, Y Zhang, K Leahy, et al.
Science (New York, N.Y.)|June 20, 1998
Aspirin-like molecules that covalently inactivate cyclooxygenase-2A S Kalgutkar, B C Crews, S W Rowlinson, et al.
The Journal of Comparative Neurology|August 15, 1992
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brainC D Breder, W L Smith, A Raz, et al.
The Journal of Biological Chemistry|June 28, 1996
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitorsJ K Gierse, J J McDonald, S D Hauser, et al.
Agents and Actions. Supplements|January 1, 1995
Mediation of inflammation by cyclooxygenase-2K Seibert, J Masferrer, Y Zhang, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Nitric oxide and the cyclooxygenase pathwayD Salvemini, K Seibert, J L Masferrer, et al.
Biochemical and Biophysical Research Communications|May 15, 1991
Post-translational processing and secretory pathway of human atriopeptin in rat pheochromocytoma cellsS Shiono, N Suganuma, M Bo, et al.
Anticancer Research|February 19, 2002
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesisH M Abou-Issa, G A Alshafie, K Seibert, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|March 1, 1995
Regulation of prostaglandin production by nitric oxide; an in vivo analysisD Salvemini, S L Settle, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1993
Nitric oxide activates cyclooxygenase enzymesD Salvemini, T P Misko, J L Masferrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and painK Seibert, Y Zhang, K Leahy, et al.
Science (New York, N.Y.)|June 20, 1998
Aspirin-like molecules that covalently inactivate cyclooxygenase-2A S Kalgutkar, B C Crews, S W Rowlinson, et al.
The Journal of Comparative Neurology|August 15, 1992
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brainC D Breder, W L Smith, A Raz, et al.
The Journal of Biological Chemistry|June 28, 1996
A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitorsJ K Gierse, J J McDonald, S D Hauser, et al.
Agents and Actions. Supplements|January 1, 1995
Mediation of inflammation by cyclooxygenase-2K Seibert, J Masferrer, Y Zhang, et al.
Advances in Prostaglandin, Thromboxane, and Leukotriene Research|January 1, 1995
Nitric oxide and the cyclooxygenase pathwayD Salvemini, K Seibert, J L Masferrer, et al.
Biochemical and Biophysical Research Communications|May 15, 1991
Post-translational processing and secretory pathway of human atriopeptin in rat pheochromocytoma cellsS Shiono, N Suganuma, M Bo, et al.
Anticancer Research|February 19, 2002
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesisH M Abou-Issa, G A Alshafie, K Seibert, et al.
Pageof 9